Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03050010 14,15-diHETrE cPLA2i 1.0 BCD110605C28 0.062 pmol/ml medium
LMFA03050010 14,15-diHETrE cPLA2i 1.0 BCD110605C30 0.072 pmol/ml medium
LMFA03050010 14,15-diHETrE cPLA2i 1.0 BCD110605C29 0.066 pmol/ml medium
LMFA03050010 14,15-diHETrE cPLA2i 20.0 BCD110605C64 0.074 pmol/ml medium
LMFA03050010 14,15-diHETrE cPLA2i 20.0 BCD110605C66 0.076 pmol/ml medium
LMFA03050010 14,15-diHETrE cPLA2i 20.0 BCD110605C65 0.074 pmol/ml medium
LMFA03050010 14,15-diHETrE PLDi 1.0 BCD110605C16 0.051 pmol/ml medium
LMFA03050010 14,15-diHETrE PLDi 1.0 BCD110605C17 0.036 pmol/ml medium
LMFA03050010 14,15-diHETrE PLDi 1.0 BCD110605C18 0.052 pmol/ml medium
LMFA03050010 14,15-diHETrE PLDi 20.0 BCD110605C54 0.059 pmol/ml medium
LMFA03050010 14,15-diHETrE PLDi 20.0 BCD110605C52 0.074 pmol/ml medium
LMFA03050010 14,15-diHETrE PLDi 20.0 BCD110605C53 0.062 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+cPLA2i 1.0 BCD110605C32 0.068 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+cPLA2i 1.0 BCD110605C31 0.069 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+cPLA2i 1.0 BCD110605C33 0.065 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+cPLA2i 20.0 BCD110605C68 0.077 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+cPLA2i 20.0 BCD110605C69 0.077 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+cPLA2i 20.0 BCD110605C67 0.077 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+PLDi 1.0 BCD110605C19 0.042 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+PLDi 1.0 BCD110605C20 0.051 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+PLDi 1.0 BCD110605C21 0.052 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+PLDi 20.0 BCD110605C56 0.068 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+PLDi 20.0 BCD110605C57 0.07 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+PLDi 20.0 BCD110605C55 0.064 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+ATP+cPLA2i 1.0 BCD110605C37 0.071 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+ATP+cPLA2i 1.0 BCD110605C38 0.067 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+ATP+cPLA2i 1.0 BCD110605C39 0.065 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+ATP+cPLA2i 20.0 BCD110605C74 0.076 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+ATP+cPLA2i 20.0 BCD110605C75 0.076 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+ATP+cPLA2i 20.0 BCD110605C73 0.08 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+ATP+PLDi 1.0 BCD110605C25 0.056 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+ATP+PLDi 1.0 BCD110605C27 0.053 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+ATP+PLDi 1.0 BCD110605C26 0.052 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+ATP+PLDi 20.0 BCD110605C61 0.081 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+ATP+PLDi 20.0 BCD110605C62 0.068 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO+ATP+PLDi 20.0 BCD110605C63 0.077 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO + ATP 1.0 BCD110605C15 0.049 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO + ATP 1.0 BCD110605C14 0.043 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO + ATP 1.0 BCD110605C13 0.042 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO + ATP 20.0 BCD110605C49 0.079 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO + ATP 20.0 BCD110605C50 0.068 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO + ATP 20.0 BCD110605C51 0.075 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO 1.0 BCD110605C08 0.035 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO 1.0 BCD110605C07 0.042 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO 1.0 BCD110605C09 0.038 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO 20.0 BCD110605C45 0.064 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO 20.0 BCD110605C44 0.057 pmol/ml medium
LMFA03050010 14,15-diHETrE KDO 20.0 BCD110605C43 0.065 pmol/ml medium
LMFA03050010 14,15-diHETrE C 0.0 BCD110605C03 0.049 pmol/ml medium
LMFA03050010 14,15-diHETrE C 0.0 BCD110605C01 0.065 pmol/ml medium